ライフサイエンスコーパス: OMI

1 OMI has significant implications for rapid cellular-leve

2 OMI probes the fluorescence intensities and lifetimes of

3 OMI resolved trastuzumab-induced changes in cellular met

4 OMI-derived summertime HCHO values are converted to annu

5 nce of ERalpha, G93A-SOD1 failed to activate OMI and the proteasome, confirming the ERalpha dependenc

6 In addition, OMI resolved cellular subpopulations of differing respon

7 In addition, OMI resolves differences in the basal metabolic activity

8 y emissions over a radius of 70 km around an OMI detection are larger than twice the emissions within

9 Therefore, an OMI organoid drug screen could enable accurate testing o

10 R = 0.93) is found between SO2 emissions and OMI-observed SO2 burdens.

11 sensitive to drug response in organoids, and OMI in tumor organoids correlates with primary tumor dru

12 OMI-derived ground-level NO2 concentrations, OMI NO2 columns, and bottom-up NOx emission inventories

13 Our derived OMI risk score provided enhanced rule-in and rule-out ac

14 opospheric NO(2) column and HCHO column from OMI as input to the ML model to enable measurement-based

15 , which use only GSV features, and (2) GSV + OMI models, which also include satellite observations of

16 models were 0.88 (GSV-only) and 0.91 (GSV + OMI)-a performance that is comparable to traditional LUR

17 days 1 to 18 (+5.7, P =.046) and 20% higher OMI between days 6 and 12 (+3.8, P =.27).

18 optotic cytochrome c, SMAC/DIABLO, and HTRA2/OMI, which promoted caspase-9 and -3 activation.

19 including clusterin, cytochrome C, and HTRA2/OMI.

20 Optical metabolic imaging (OMI) is a noninvasive, high-resolution, quantitative too

21 Specifically, optical metabolic imaging (OMI) is highly sensitive to drug response in organoids,

22 Here we use optical metabolic imaging (OMI), a non-invasive, label-free method to evaluate sing

23 Importantly, OMI endpoints remained unchanged with trastuzumab treatm

24 onymous mutation and a novel polymorphism in OMI/HTRA2 locus have been associated with Parkinson's di

25 measures included the oral mucositis index (OMI), speed of engraftment (platelet and granulocyte cou

26 2 to 3 days using the Oral Mucositis Index (OMI).

27 tients with occlusion myocardial infarction (OMI) and no ST-elevation on presenting electrocardiogram

28 (AIRS) CO, Aura Ozone Monitoring Instrument (OMI) aerosol index, and Aura Microwave Limb Sounder (MLS

29 ations from the Ozone Monitoring Instrument (OMI) for Indian coal-fired power plants during the OMI e

30 rvations of the Ozone Monitoring Instrument (OMI) for tropospheric sulfur dioxide (SO(2)) and formald

31 ts, made by the Ozone Monitoring Instrument (OMI) on NASA's Aura satellite in 2005-2015.

32 pixels from the Ozone Monitoring Instrument (OMI) over 18 NO2 hotspots in China.

33 columns by the Ozone Monitoring Instrument (OMI) over China from 2005 to 2010 in order to estimate t

34 method for the Ozone Monitoring Instrument (OMI) sensor enabled detection of lower tropospheric O(3)

35 ty in satellite Ozone Monitoring Instrument (OMI) tropospheric column NO2 densities.

36 ations from the Ozone Monitoring Instrument (OMI) were used to examine trends in nitrogen dioxide (NO

37 s exceed recent Ozone Monitoring Instrument (OMI)-derived year-to-year decreases from emission contro

38 rieved from the Ozone Monitoring Instrument (OMI).

39 gn and synthesis of oxide-metal interaction (OMI) catalyst under oxidative atmospheres.

40 Intraprocedural OMI was successfully performed in six lesions (two lesio

41 bjective of this perspective is to introduce OMI and tumor organoids to a general audience in order t

42 uring days 6 to 12, 1 to 18, and the maximum OMI score between days 1 to 18.

43 R activity (TT genotype) had 36% higher mean OMI during days 1 to 18 (+5.7, P =.046) and 20% higher O

44 e were found to be predictive of higher mean OMI scores (P <.05).

45 upplement use was associated with lower mean OMI scores compared to those who did not use supplements

46 ysis was used to identify predictors of mean OMI during days 6 to 12, 1 to 18, and the maximum OMI sc

47 compatibility were not associated with mean OMI scores.

48 n a CRISPR-edited anti-GD2 CAR T cell model, OMI measurements allow accurate prediction of an oxidati

49 The stability of this new OMI catalyst was explained through density functional th

50 ine learning models for the ECG diagnosis of OMI.

51 not male, G93A-SOD1 mice showed elevation of OMI and proteasome activity.

52 ion, we analyzed the entire coding region of OMI/HTRA2 in a series of 644 North American PD cases wit

53 The clinical translation of OMI to percutaneous hepatic interventions was demonstrat

54 The 14-amino analogue of oxymorphindole (OMI) was synthesized and found to possess delta-opioid b

55 dian overall added procedure time to perform OMI was 2 minutes.

56 regulate the proteasome and the IMS protease OMI.

57 ersampling technique, yearly high-resolution OMI maps for the whole domain of India are created, and

58 oxide (SO(2)) emission estimates from NASA's OMI point source catalog for the contiguous US by compar

59 our spaceborne instruments: GOME, SCIAMACHY, OMI, and GOME-2.

60 g year(-1) produce statistically significant OMI signals, and a high correlation (R = 0.93) is found

61 ar, the core (Pd)-shell (TiO(2) ) structured OMI catalyst exhibited excellent resistance to SO(2) poi

62 Our data support OMI as a robust, sensitive analytical tool to optimize m

63 We confirm that OMI correlates with cellular glycolytic levels across a

64 We demonstrate that OMI parameters can indicate cell cycle stage and optimal

65 The OMI measurements permit estimation of SO2 emissions from

66 The OMI-derived surface NO2 data are significantly correlate

67 The OMI-derived trends were found to be consistent with thos

68 or Indian coal-fired power plants during the OMI era of 2005-2012.

69 tigated the statistical significance for the OMI sensor to detect the lower tropospheric O(3) respons

70 he method to satellite observations from the OMI (NO(2)) and IASI (NH(3)) in 2017.

71 05-2016 summertime HCHO column data from the OMI satellite instrument, validated with high-quality ai

72 We examine how the OMI-derived ground-level NO2 concentrations, OMI NO2 col

73 ignal from volcanic eruptions present in the OMI data.

74 r than twice the emissions within 40 km, the OMI value is consistently overestimated.

75 ithin only 13 years of the 2005 start of the OMI/MLS satellite record.

76 ort model (GEOS-Chem) are used to relate the OMI NO2 columns to ground-level concentrations.

77 We find that the OMI-based SO(2) emissions are accurate in aggregate, whe

78 binding affinity and selectivity similar to OMI.

79 ted by the Indian Government, both the total OMI-observed SO2 and annual average SO2 concentrations i

80 Using OMI, we identified the impacts of media composition on C

81 In vivo OMI is sensitive to metabolic changes induced by inhibit

82 High-O(3) events vary nonlinearly with OMI HCHO and NO(2), and the transition from VOC-limited

83 window for the Pfizer-BioNTech BNT162b2; WT/OMI BA.4/BA.5 COVID-19 bivalent vaccine (IRR, 1.20 [95%

84 ho received the Pfizer-BioNTech BNT162b2; WT/OMI BA.4/BA.5 COVID-19 bivalent vaccine.